103 related articles for article (PubMed ID: 12845676)
1. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk.
Chang BL; Zheng SL; Isaacs SD; Turner A; Hawkins GA; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Int J Cancer; 2003 Sep; 106(3):375-8. PubMed ID: 12845676
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner A; Hawkins GA; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Br J Cancer; 2003 Oct; 89(8):1524-9. PubMed ID: 14562027
[TBL] [Abstract][Full Text] [Related]
3. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer.
Wright CM; Larsen JE; Colosimo ML; Barr JJ; Chen L; McLachlan RE; Yang IA; Bowman RV; Fong KM
Eur Respir J; 2010 Jan; 35(1):152-9. PubMed ID: 19608585
[TBL] [Abstract][Full Text] [Related]
4. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
6. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
7. Role of CYP1A1 haplotypes in modulating susceptibility to coronary artery disease.
Lakshmi SV; Naushad SM; Saumya K; Rao DS; Kutala VK
Indian J Biochem Biophys; 2012 Oct; 49(5):349-55. PubMed ID: 23259321
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis.
Li H; Xiao D; Hu L; He T
Mol Biol Rep; 2012 Dec; 39(12):10273-84. PubMed ID: 23065259
[TBL] [Abstract][Full Text] [Related]
9. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].
Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV
Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617
[TBL] [Abstract][Full Text] [Related]
10. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
Zheng SL; Chang BL; Faith DA; Johnson JR; Isaacs SD; Hawkins GA; Turner A; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Nov; 62(22):6485-8. PubMed ID: 12438241
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
Guan TY; Li M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
13. [Association of nasopharyngeal carcinoma risk with cytochrome P450 CYP1A1 gene polymorphisms].
Xu YF; Pan QH; Cui C; Chen LZ; Feng QS; Zeng YX; Jia WH
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):586-90. PubMed ID: 19954069
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia.
Salnikova LE; Smelaya TV; Moroz VV; Golubev AM; Rubanovich AV
Int J Infect Dis; 2013 Jun; 17(6):e433-42. PubMed ID: 23411129
[TBL] [Abstract][Full Text] [Related]
15. Impact of CYP1A1, GSTM1, and GSTT1 polymorphisms in overall and specific prostate cancer survival.
Acevedo CA; Quiñones LA; Catalán J; Cáceres DD; Fullá JA; Roco AM
Urol Oncol; 2014 Apr; 32(3):280-90. PubMed ID: 24508281
[TBL] [Abstract][Full Text] [Related]
16. Genotype frequencies of polymorphic GSTM1, GSTT1, and cytochrome P450 CYP1A1 in Mexicans.
Montero R; Araujo A; Carranza P; Mejía-Loza V; Serrano L; Albores A; Salinas JE; Camacho-Carranza R
Hum Biol; 2007 Jun; 79(3):299-312. PubMed ID: 18078203
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
Liu QX; Chen HC; Liu XF; Cao YF; Zhang J; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):975-9. PubMed ID: 16676594
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the cytochrome P450 (CYP1A1) gene polymorphism in the ethnic groups of the Republic of Bashkortostan].
Kochetova OV; Korytina GF; Akhmadishina LZ; Iskhakov GM; Victorova TV
Genetika; 2008 Dec; 44(12):1677-83. PubMed ID: 19178087
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
Shaik AP; Jamil K; Das P
Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
